-
1كتاب
المؤلفون: Samhani, C, Guerci, B, Larose, C
المصدر: Diabetes Metab ; ISSN:1878-1780
مصطلحات موضوعية: Cutaneous hypersensitivity reactions, Dulaglutide, Glucagon-like peptide 1, Type II diabetes
العلاقة: https://doi.org/10.1016/j.diabet.2024.101552Test; https://pubmed.ncbi.nlm.nih.gov/38942076Test
الإتاحة: https://doi.org/10.1016/j.diabet.2024.101552Test
https://pubmed.ncbi.nlm.nih.gov/38942076Test -
2دورية أكاديمية
المؤلفون: Hachuła, Marcin, Basiak, Marcin, Kosowski, Michał, Okopień, Bogusław
المصدر: Life (Basel) ; ISSN:2075-1729 ; Volume:14 ; Issue:6
مصطلحات موضوعية: GLP-1 receptor agonist, ICAM-1, MCP-1, atherosclerosis, diabetes mellitus, dulaglutide, semaglutide
العلاقة: https://doi.org/10.3390/life14060690Test; https://pubmed.ncbi.nlm.nih.gov/38929672Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11204864Test/
الإتاحة: https://doi.org/10.3390/life14060690Test
https://pubmed.ncbi.nlm.nih.gov/38929672Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11204864Test/ -
3دورية أكاديمية
المؤلفون: Hachuła, Marcin, Kosowski, Michał, Basiak, Marcin, Okopień, Bogusław
المصدر: Medicina (Kaunas) ; ISSN:1648-9144 ; Volume:60 ; Issue:6
مصطلحات موضوعية: GLP-1 receptor agonist, MMP-9, copeptin, diabetes mellitus, dulaglutide, lipoprotein(a), pentraxin 3, semaglutide
العلاقة: https://doi.org/10.3390/medicina60060908Test; https://pubmed.ncbi.nlm.nih.gov/38929525Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11205508Test/
الإتاحة: https://doi.org/10.3390/medicina60060908Test
https://pubmed.ncbi.nlm.nih.gov/38929525Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11205508Test/ -
4دورية أكاديمية
المصدر: Front Pharmacol ; ISSN:1663-9812 ; Volume:15
مصطلحات موضوعية: CGM, GIP, GLP-1, continuous glucose monitoring, dulaglutide, glycemic control, hemodialysis, tirzepatide
العلاقة: https://doi.org/10.3389/fphar.2024.1362242Test; https://pubmed.ncbi.nlm.nih.gov/38873429Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11169618Test/
الإتاحة: https://doi.org/10.3389/fphar.2024.1362242Test
https://pubmed.ncbi.nlm.nih.gov/38873429Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11169618Test/ -
5دورية أكاديمية
المؤلفون: Al Refaie, Antonella, Baldassini, Leonardo, Mondillo, Caterina, Ceccarelli, Elena, Tarquini, Roberto, Gennari, Luigi, Gonnelli, Stefano, Caffarelli, Carla
المصدر: Calcif Tissue Int ; ISSN:1432-0827
مصطلحات موضوعية: Bone mineral density (BMD), Bone turnover markers, Dual-energy X-ray absorptiometry (DXA), Dulaglutide, Radiofrequency echographic multispectrometry (REMS), Semaglutide, Trabecular bone score (TBS), Type 2 diabetes mellitus (T2DM)
العلاقة: https://doi.org/10.1007/s00223-024-01240-1Test; https://pubmed.ncbi.nlm.nih.gov/38864922Test
-
6دورية أكاديمية
المصدر: Diabetes Res Clin Pract ; ISSN:1872-8227 ; Volume:213
مصطلحات موضوعية: Dulaglutide, GLP-1 receptor agonists, Glycaemic control, weight, Medication shortages, Semaglutide, Type 2 diabetes
العلاقة: https://doi.org/10.1016/j.diabres.2024.111740Test; https://pubmed.ncbi.nlm.nih.gov/38852625Test
الإتاحة: https://doi.org/10.1016/j.diabres.2024.111740Test
https://pubmed.ncbi.nlm.nih.gov/38852625Test -
7دورية أكاديمية
المؤلفون: Zheng, Shuihong, Huang, Huaying, Chen, Heye, Liu, Yanfen
المصدر: Appl Biochem Biotechnol ; ISSN:1559-0291 ; Volume:195 ; Issue:8
مصطلحات موضوعية: Dulaglutide, Insulin, Metformin, Non-alcoholic fatty liver disease, Sulfonyl urea, Type 2 diabetes
العلاقة: https://doi.org/10.1007/s12010-023-04505-xTest; https://pubmed.ncbi.nlm.nih.gov/37140780Test
-
8مراجعة
المصدر: Arch Dermatol Res ; ISSN:1432-069X ; Volume:316 ; Issue:6
مصطلحات موضوعية: Cutaneous adverse effects, Dulaglutide, Exenatide, GLP-1 agonists, Glucagon-like-peptide-1, Hemoglobin A1c, Liraglutide, Lixisenatide, Semaglutide, Tirzepatide, Type 2 diabetes mellitus, Weight loss
العلاقة: https://doi.org/10.1007/s00403-024-02969-3Test; https://pubmed.ncbi.nlm.nih.gov/38795152Test